- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Cost-Effective Interventions to Fight Childhood Obesity
When evaluating the cost-effectiveness of 4 different interventions to prevent or reduce childhood obesity, researchers found that the benefit of these interventions surpassed the current clinical interventions to treat obesity.
As the obesity epidemic continues to hound healthcare providers, policy makers, and the government, scientists are working to develop alternate models to prevent, rather than treat, the condition. A paper published in the July issue of the American Journal of Preventive Medicine evaluated the impact of 4 childhood obesity interventions: sugar-sweetened beverage excise tax (SSB), eliminating tax subsidy of TV advertising to children (TV AD), early care and education policy change (ECE), and active physical education (active PE).
The simulation model used in the study created a representative US population for a 10-year period between 2015 and 2025. The results of the simulated study showed that 3 of the 4 interventions would yield net savings: SSB, TV AD, and active PE. While SSB and TV AD would create tax revenue, they'd also avert disability-adjusted life years while improving quality-adjusted life years. These intervention, the authors write, are more cost-effective than current clinical interventions to treat obesity.
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Many Patients With Psoriasis in Clinical Trials Experience Nocebo Effects, Study Finds
April 18th 2024Half of patients exposed to placebo in clinical trials experienced adverse events (AEs), which may be partially explainable by nocebo effects, according to a recent review and meta-analysis.
Read More
